Phase 1 Advanced Malignant Solid Tumor Clinical Trials
27 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–20 of 27 trials
Recruiting
Phase 1
CT-95 in Advanced Cancers Associated With Mesothelin Expression
Colorectal, CancerMesothelin-Expressing TumorsEpithelial Ovarian Cancer+8 more
Context Therapeutics Inc.70 enrolled9 locationsNCT06756035
Recruiting
Phase 1Phase 2
A Study of MHB042C in Patients With Advanced Solid Tumors
Advanced Malignant Solid Tumor
Minghui Pharmaceutical (Hangzhou) Ltd200 enrolled1 locationNCT07192107
Recruiting
Phase 1Phase 2
A Study of MHB009C in Patients With Advanced Solid Tumors
Advanced Malignant Solid Tumor
Minghui Pharmaceutical (Hangzhou) Ltd200 enrolled1 locationNCT07326488
Recruiting
Phase 1Phase 2
A Study of MHB048C in Patients With Advanced Solid Tumors
Advanced Malignant Solid TumormCRPC (Metastatic Castration-resistant Prostate Cancer)
Minghui Pharmaceutical (Hangzhou) Ltd200 enrolled1 locationNCT07192120
Recruiting
Phase 1
Trial to Assess the Safety and Antitumor Activity of GEN1057 in Malignant Solid Tumors
Advanced malignant solid tumorsMetastatic Malignant Solid Tumors
Genmab45 enrolled5 locationsNCT06573294
Recruiting
Phase 1
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2062 in Patients With Solid Tumors
Advanced Malignant Solid Tumor
Shanghai Virogin Biotech Co., Ltd.30 enrolled1 locationNCT07262164
Recruiting
Phase 1Phase 2
A Study of FC084CSA in Combination of Tislelizumab in Patients With Advanced Malignant Solid Tumors
Advanced malignant solid tumors
FindCure Biosciences (ZhongShan) Co., Ltd.33 enrolled1 locationNCT06499350
Recruiting
Phase 1
A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
Solid Tumor CancerAdvanced Malignant Solid Tumor
Pilatus Biosciences Inc36 enrolled2 locationsNCT07337525
Recruiting
Phase 1Phase 2
An Early Phase Trial of RPTR-1-201 in Advanced Solid Tumors
Advanced Malignant Solid Tumor
Repertoire Immune Medicines150 enrolled1 locationNCT07293754
Recruiting
Phase 1
A Study of CSCJC3456 in Patients With Advanced Malignant Tumors
Advanced malignant solid tumors
Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd.102 enrolled2 locationsNCT06717750
Recruiting
Phase 1
A Study to Compare the Blood Levels and Safety of Tazemetostat in Participants With Advanced Cancer and Moderate/Severe Liver Impairment to Participants With Advanced Cancer and Normal Liver Function
Advanced Malignant Solid TumorHepatic Impairment
Epizyme, Inc.24 enrolled18 locationsNCT04241835
Recruiting
Phase 1
JSKN022 in Subjects With Advanced Malignant Solid Tumors
Advanced malignant solid tumors
Jiangsu Alphamab Biopharmaceuticals Co., Ltd225 enrolled1 locationNCT07292402
Recruiting
Phase 1Phase 2
A Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Solid Tumors
Advanced Malignant Solid Tumor
Minghui Pharmaceutical (Hangzhou) Ltd116 enrolled1 locationNCT07126665
Recruiting
Phase 1Phase 2
Phase I/II Study of SCTB39-1 in Advanced Solid Tumours
Advanced Malignant Solid Tumor
Sinocelltech Ltd.110 enrolled1 locationNCT07050641
Recruiting
Phase 1
A Study of MHB118C Injection in Patients With Advanced Solid Tumors
Advanced Malignant Solid Tumor
Minghui Pharmaceutical (Hangzhou) Ltd200 enrolled1 locationNCT07045454
Recruiting
Phase 1
MT027 in Patients With Advanced Peritoneal Malignancies or Abdominal Metastatic Solid Tumors
B7-H3-positive Advanced Malignant Solid Tumors Advanced Primary Peritoneal Tumors or Secondary Abdominal Metastatic Malignant Solid Tumors
Zhejiang University12 enrolled1 locationNCT06912152
Recruiting
Phase 1
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2025 in Patients with Solid Tumors
Advanced Malignant Solid Tumor
Shanghai Virogin Biotech Co., Ltd.30 enrolled1 locationNCT05477849
Recruiting
Phase 1
Phase I Study of WJ47156 Monotherarpy and in Combination With Other Therapy in Advanced Solid Tumors
Advanced malignant solid tumors
Shanghai Junshi Bioscience Co., Ltd.93 enrolled1 locationNCT06571422
Recruiting
Phase 1Phase 2
A Study of GQ1010 in Subjects With Advanced Solid Tumors
Advanced malignant solid tumors
GeneQuantum Healthcare (Suzhou) Co., Ltd.260 enrolled5 locationsNCT06464055
Recruiting
Phase 1
A Clinical Research About CD70-targeted CAR-NKT Cells Therapy in Subjects with Advanced Malignant Solid Tumors
Advanced malignant solid tumors
Peking University Cancer Hospital & Institute13 enrolled1 locationNCT06728189